Apg Asset Management Us Inc. Incyte Corp Transaction History

Apg Asset Management Us Inc.

  • $14.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$51.18 - $63.75 $66,380 - $82,683
1,297 Added 2.43%
54,683 $3.31 Million
Q1 2024

May 14, 2024
BUY
$56.55 - $66.59 $951,849 - $1.12 Million
16,832 Added 46.05%
53,386 $3.04 Million
Q4 2023

Feb 13, 2024
BUY
$52.16 - $64.19 $1.91 Million - $2.35 Million
36,554 New
36,554 $2.3 Million

Others Institutions Holding INCY

# of Institutions
644
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Apg Asset Management Us Inc. Portfolio

Follow Apg Asset Management Us Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management Us Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email